Randomised, open, prospective, multicenter pilot study to evaluate the efficacy and safety of activated recombinant factor Viia (Novoseven) in acute intracerebral haemorrhage in patients treated with oral anticoagulant or antiplatelet agents

Internal Medicine-Stroke Unit, University of Perugia, Perugia; 2Stroke Unit, Policlinico Umberto I, Roma; 3Emergency Department, Padova hospital, Padova

ISTH Congress. 2007;: Abstract No. P-T-162.
Study details